This site uses cookies. By using this site you agree to receiving cookies. View Policy.

29%

Tourniglo is the world’s first multi-use, quick-release phlebotomy tourniquet with a built-in torch. Its potential has been recognised by retailers and distributors who have expressed interest in stocking the Tourniglo. The global tourniquet market is anticipated to expand at a CAGR of 8%.

  • UK retailers have expressed an interest in buying the product
  • One retailer has already placed the device on their e-commerce website
  • Tourniquet systems market worth $594.8 million by 2025
  • Ongoing discussion with large UK distributor with exporting potential

Idea

Tourniglo is the first branded, multi-use, phlebotomy tourniquet with a built-in torch in the world (patent-pending). Its design was driven by an identified need within the emergency services to provide an immediately available light source in darkened areas when undertaking a patient or casualty eye examination, or when looking for their vital sign that can reduce the decision-making time for taking drastic action.

It also has important applications for military and close protection staff who might need to inject intravenous medication in rural areas. Its versatile use can potentially make it an essential element of a first aid kit, as well as of bleeding kits.

The global tourniquet market is forecast to witness a CAGR of 8% between 2018–2024. The global tourniquet systems market is expected to reach $594.8m by 2025.

Dr Stratos Sofos created early prototypes and founded Tourniglo Ltd in 2012. Alexander joined the company in 2015, and with his design engineering background the product evolved into its current form. Since late 2018, we have received buying interest from retailers and distributors.

Tourniglo has been featured on the BBC website and has won various medals at international events, including Gold at the World Invention Awards.

This seed funding will be used to set-up manufacturing, packaging and distribution, and grow sales for the first year of commercialisation.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the Tourniglo pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered? Log in

This pitch is approved by Crowdcube

This pitch is approved as a financial promotion by Crowdcube Capital Limited. Every pitch on Crowdcube is reviewed to ensure it is fair, clear and not misleading.

As part of our commitment to investor transparency, Crowdcube’s Due Diligence Charter outlines the analysis and verification that is conducted on equity fundraises on Crowdcube by our legal and compliance professionals.

Read more

Risk warning

Investments of this nature carry risks to your capital, including illiquidity, lack of dividends and dilution. Balance risk with a diversified portfolio. Read more. Approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.

Tourniglo has been given advance assurance by HMRC that the proposed share issue is likely to qualify for Enterprise Investment Scheme (EIS) tax relief.

Tax relief is available to individuals only, with income tax relief currently set at 30 per cent of the cost of the shares for the tax year in which the investment was made. The tax reliefs can also reduce your Capital Gains Tax bill. Read More.

Availability of tax relief depends on your individual and the company’s ongoing circumstances and applicable law.